Literature DB >> 36248300

Estimation of 10-Year Risk of Cardiovascular Diseases Using WHO Risk Prediction Charts: A Population-Based Study in Southern Iran.

Fatemeh Rezaei1, Mozhgan Seif2, Mohammad Reza Fattahi3, Abdullah Gandomkar4, Jafar Hasanzadeh5.   

Abstract

Background: An effective strategy for primary prevention of Cardiovascular Disease (CVD) is accurate diagnosis and the subsequent evidence-based treatment for high-risk people. This study aimed to estimate the 10-year risk of CVD and its related factors.
Methods: The baseline data of 8138 participants of the Pars cohort study (PCS) in southern Iran were used. Risk scores were calculated using the updated 2019 WHO CVD risk prediction charts. The scores were determined based on age, gender, current smoking status, systolic blood pressure (SBP), diabetes status, and total serum cholesterol. Demographic and socioeconomic variables, physical activity, and anthropometric indices were measured and analyzed. Multivariable logistic regression was applied to estimate the adjusted odds ratio (aOR) and 95% confidence intervals (CI).
Results: The mean (SD) age of the participants was 51.65 (9.06) years, and 53.44% were female. The 10-year CVD risk for 23.89% of participants was ≥10%. The prevalence of hypertension, diabetes, hypercholesterolemia, and smoking was 12.79%, 8.38%, 12.80%, and 14.41%, respectively. Having abdominal obesity, having low or moderate physical activity, being illiterate or having diplomas or lower degrees, and being in the third quartile of the wealth score group were associated with a higher 10-year risk of CVD.
Conclusion: About one-fourth of the participants had moderate risk and higher. Due to the relatively high prevalence of CVD risk factors in the middle-aged population, the modifiable risk factors are recommended to be adjusted. Additionally, individual- and community-based educational policies are essential to create a healthy lifestyle.
Copyright © 2022 Rezaei et al. Published by Tehran University of Medical Sciences.

Entities:  

Keywords:  Cardiovascular diseases; Cohort studies; Life style; Prediction model; Socioeconomic factors

Year:  2022        PMID: 36248300      PMCID: PMC9529739          DOI: 10.18502/ijph.v51i7.10101

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.479


Introduction

Cardiovascular Diseases (CVD) are chronic and non-communicable diseases, which are responsible for more than 12% of the global burden of disease (1). The number of CVD patients is expected to increase due to lifestyle changes in the coming years (2, 3). This increase is not limited to low- and middle-income countries, and the leading cause of disease burden is related to CVD even in high-income countries (3). In 2015, 422.7 million cases of CVD and 17.92 million CVD deaths occurred in the world (4). Furthermore, 1.4 million CVD deaths occurred in the Eastern Mediterranean Region (5). In Iran, CVDs are quite prevalent, accounting for 50% of all deaths and 79% of deaths related to chronic diseases each year (6, 7). Hypertension, diabetes, obesity, smoking, and hypercholesterolemia are the most important risk factors for CVD. These risk factors can be prevented and controlled by implementing some effective interventions (8). Since the treatment of such diseases imposes high costs on healthcare systems, it is essential to evaluate the risk factors of CVD. Many tools, including the Framingham risk score (FRS) and World Health Organization/International Society of Hypertension (WHO/ISH), have been developed to predict CVD risk. These tools can help identify people at risk and, as a result, increase their awareness of disease prevention. In 2007, WHO/ISH risk charts were published for all WHO epidemiological sub-regions. WHO updated CVD risk charts based on recently validated risk prediction models to determine the risk of CVD in 21 Global Burden of Disease (GBD) regions in 2019 (9). For this version, data were recalibrated by region-specific incidences from GBD and country-specific risk factors from non-communicable disease Risk Factor Collaboration (NCD-RisC) (10). Since the prevalence of CVD is high in low- and middle-income countries like Iran, primary prevention has been considered the most useful and cost-effective strategy due to the high burden and therapeutic cost of CVD. International clinical guidelines for accurate identification and subsequent evidence-based treatment of people at high risk for CVD have recommended the application of CVD risk assessment tools in routine clinical practice (11). In Iran, some studies have used different CVD risk prediction models such as FRS and WHO charts (12–14). In 2017, a risk chart for CVD in Eastern Mediterranean Region was presented by Sarrafzadegan et al (15). Considering that CVD is the most important cause of death in the Iranian population, the present study aims to estimate the 10-year risk of CVD and its related factors in the Pars cohort population using WHO risk prediction charts updated in 2019.

Materials and Methods

Participants and Settings

The present study was a part of the Pars cohort study (PCS). The PCS was designed and implemented in collaboration with research teams from the Non-Communicable Diseases Research Center (NCDRC) of Shiraz University of Medical Sciences (SUMS) and the Digestive Diseases Research Institute (DDRI) of Tehran University of Medical Sciences (TUMS). In this study, the baseline data of PCS were used, in which all residents of Valashahr aging 40–75 years (9721 individual) were invited to participate in 2014. Eventually, 9264 individuals (95%) went to the Pars Cohort Center for interviews and limited physical examinations. For all participants, demographic characteristics, lifestyle variables, and disease history were registered by trained interviewers. Anthropometric indices such as height, weight, and also blood pressure (BP) were measured. For biochemical tests, a blood sample was taken. Further details of the study protocol and the preliminary results have already been published (16). Ihe cases with a history of CVD or stroke were excluded. The final sample size included 8138 cases.

Ethics approval

This study was approved by the Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.REC.1398.860). All participants were required to sign informed consent forms and the data were gathered anonymously.

WHO risk prediction charts

There are two versions of the WHO risk chart based on the presence or absence of cholesterol. The version used in this study was based on the presence of cholesterol data. To calculate the risk of fatal and non-fatal events of CVD (i.e., myocardial infarction and stroke) using WHO risk assessment, age, gender, current smoking status, SBP in mmHg, diabetes status, and total serum cholesterol (in mmol/L) were used. In the WHO risk models, the individuals were classified into very low (<5%), low (5 to <10%), moderate (10% to <20%), high (20% to <30%), and very high risk (≥30%) groups (9). It is worth mentioning that the authors have already estimated the FRS for this population (13).

Definition of Variables

In addition to the variables used to determine the 10-year CVD risk, other variables were also examined, including education, wealth score, physical activity, and abdominal obesity. These variables were collected at baseline. Smoking status was obtained from the interview. Blood samples were measured for biochemical tests in a fasting state for 8 to 12 hours. Diabetes was determined according to past medical histories or fasting blood sugar (FBS) ≥126 mg/dl (17). Cholesterol has been tested in the laboratory. Hypercholesterolemia was defined as total cholesterol level ≥6.21 mmol/L (18). BP was measured in the sitting position using a mercury sphygmomanometer after five minutes of rest. For each person, BP was measured twice on each arm and the average value was recorded (13, 14). According to the JNC8 criteria, hypertension was defined as SBP ≥ 140 mmHg, or diastolic blood pressure (DBP) ≥ 90 mmHg (19), or taking medications. Age was categorized into two groups; i.e., <55 and ≥55 years. Education level was categorized into three groups, namely illiterate, diplomas or lower degrees, and academic. The wealth score was calculated for each participant based on a combination of different parameters given different weights. These parameters included having a personal car, motorbike, TV, refrigerator, freezer, vacuum cleaner, and washing machine as well as having a house and its size and structure. Occupation was considered for the calculation of the wealth score. This method was described by Islami et al (20). The wealth score was divided to five quintiles. Physical activity was measured using the metabolic equivalent rate (METs) of self-report daily activities using the International Physical Activity Questionnaire (IPAQ). Then, MET scores were categorized into three thirties: low, moderate, and high physical activity. Abdominal obesity was defined as a waist to hip ratio ≥0.9 for males and ≥0.85 for females (19).

Statistical Analysis

Continuous and discrete variables were presented with mean ± standard deviation (SD), and percentage, respectively. For categorical and continuous variables, chi-square and t-test were used, respectively. The prevalence of CVD risk factors and the 10-year CVD risk were calculated. The participants were divided into two risk groups of <10% and ≥10%. Crude and adjusted odds ratios (aOR) and their 95% CI were estimated. Variables were included in the multivariable logistic regression according to a bivariate P-value < 0.25. Data analysis was performed in 2020. Statistical analyses were performed using Stata, version 14.0 for Windows (Stata Corp., College Station, TX, USA). The significance level was set at 0.05.

Results

In this study, 53.44% of the participants were female, and 66.45% were <55-years. The prevalence of smoking was 14.41%. The prevalence of hypertension and diabetes was 12.79% and 8.38%, respectively. See Table 1 for an overview.
Table 1:

Baseline demographic, anthropometric, and metabolic characteristics of the study participants

Variables Total (n=8138) Males (n=3789) Females (n=4349) P-value

N (%)N (%)N (%)
Age range (yr)
<555408 (66.45)2491 (65.74)2917 (67.07)0.205
≥552730 (33.55)1298 (34.26)1432 (32.93)
Education level
Illiterate3795 (46.63)1107 (29.22)2688 (61.81)<0.001
≤diploma4081 (50.15)2438 (64.34)1643 (37.78)
University262 (3.22)244 (6.44)18 (0.41)
Wealth score
Quintile 11911 (23.48)748 (19.74)1163 (26.74)<0.001
Quintile 21360 (16.71)610 (16.10)750 (17.25)
Quintile 31742 (21.41)813 (21.46)929 (21.36)
Quintile 41463 (17.98)732 (19.32)731 (16.81)
Quintile 51662 (20.42)886 (23.38)776 (17.84)
Physical activity
Low2715 (33.36)849 (22.41)1728 (39.73)<0.001
Medium2711 (33.31)1058 (27.92)1665 (38.28)
High2712 (33.33)1882 (49.67)956 (21.98)
Smoking (now)
No6965 (85.59)2644 (69.78)4321 (99.36)<0.001
Yes1173 (14.41)1145 (30.22)28 (0.64)
Hypertension
No7097 (87.21)3517 (92.82)3580 (82.32)<0.001
Yes1041 (12.79)272 (7.18)769 (17.68)
Diabetes
No7456 (91.62)3585 (94.62)3871 (89.01)<0.001
Yes682 (8.38)204 (5.38)478 (10.99)
DBP (Mean mmHg ±73.16±11.7773.44±11.6172.92±11.910.045
SD )
SBP (Mean mmHg ±111.19 ± 18.68110.78±17.50111.54±19.640.066
SD )
Hypercholesterolemia
No7096 (87.20)3476 (91.74)3620 (83.24)<0.001
Yes1041 (12.80)313 (8.26)729 (16.76)
Abdominal obesity
No1578 (19.39)1114 (29.40)464 (10.67)<0.001
Yes6560 (80.61)2675 (70.60)3885 (89.33)

DBP=diastolic blood pressure; SBP=systolic blood pressure.

Baseline demographic, anthropometric, and metabolic characteristics of the study participants DBP=diastolic blood pressure; SBP=systolic blood pressure. The 10-year CVD risk according to the examined variables has been presented in Table 2. Accordingly, the majority of cases (76.11%) were in the very low- and low-risk group. In addition, 18.17%, 4.58%, and 1.14% of the participants belonged to the moderate, high, and very high risk groups, respectively.
Table 2:

The prevalence of 10-year cardiovascular risk in the study participants based on the study variables

Variables Very Low risk N (%) Low risk N (%) Moderate risk N (%) High risk N (%) Very high risk N (%) Total N (%)
Total3796(46.65)2397 (29.46)1479 (18.17)373 (4.58)93 (1.14)8138 (100)
Age range (years)
<553744 (69.23)1419 (26.24)234 (4.32)8 (0.15)3 (0.06)5408 (100)
≥5552(1.91)978 (35.82)1245 (45.60)365 (13.37)90 (3.30)2730 (100)
Gender
Male1151(40.93)1236 (32.62)730 (19.27)201 (5.30)71 (1.87)3589 (100)
Female2245(51.62)1161 (26.70)749 (17.22)172 (3.95)22 (0.51)4349 (100)
Education level
Illiterate1178(31.04)1224 (32.25)1026 (27.04)295 (7.77)72 (1.90)3795 (100)
≤diploma2457(60.21)1097 (26.88)429 (10.51)77(1.89)21 (0.51)4081 (100)
University161(61.45)76 (29.01)24 (9.16)1 (0.38)0 (0)262 (100)
Wealth score
Quintile 1815(42.65)547 (28.62)407 (21.30)120 (6.28)22 (1.15)1911 (100)
Quintile 2602(44.26)407 (29.93)254(18.68)72 (5.29)25 (1.84)1360 (100)
Quintile 3755(43.34)529 (30.37)342 (19.63)91 (5.22)25 (1.44)1742 (100)
Quintile 4721(49.28)441 (30.14)237(16.20)51 (3.49)13 (0.89)1463 (100)
Quintile 5903(54.33)473 (28.46)239(14.38)39(2.35)8 (0.48)1662 (100)
Physical activity
Low1219(44.90)688 (25.34)582 (21.44)177 (6.52)49 (1.80)2715 (100)
Medium1286(47.44)813 (29.99)470 (17.34)110 (4.06)32 (1.18)2711 (100)
High1291(47.60)896 (33.04)427(15.74)86 (3.17)12 (0.44)2712 (100)
Abdominal obesity
No887(56.21)418 (26.49)209 (13.24)50 (3.17)14 (0.89)1578 (100)
Yes2909(44.34)1979 (30.17)1270 (19.36)323 (4.92)79 (1.20)6560 (100)
The prevalence of 10-year cardiovascular risk in the study participants based on the study variables The CVD risk increased by age. The majority of <55-year-old cases (95.47%) were in the very low- and low-risk group, while 45.60%, 13.37%, and 3.30% of the ≥55-year-old cases belonged to the moderate-, high-, and very high-risk groups, respectively. There was a larger number of males (1.87%) in the very high-risk groups compared to females (0.51%). The crude and adjusted effect of independent variables on the 10-year risk for CVD has been presented in Table 3. The adjusted model shows that the 10-year CVD risk was higher in illiterate people (aOR; 5.79, CI; 3.77–8.88) and individuals with diplomas or lower degrees (aOR; 1.54, CI; 1.003–2.35) compared with those with academic degrees. The 10-year CVD risk was higher in the third quartile (aOR;1.25, CI; 1.04–1.49) compared with those within the highest wealth score group. In the Participants with abdominal obesity, the 10-year risk of CVD was higher (aOR;1.36, CI; 1.17–1.59) compared with those without abdominal obesity. Also, Participants with low (aOR;1.76, CI; 1.54–2.01) and moderate (aOR;1.17, CI; 1.02–1.34) physical activity had a higher 10-year risk of CVD than others.
Table 3:

Crude and adjusted effect of independent variables on 10-year risk for CVD

Variables CVD risk <10% N=6193 CVD risk ≥10% N=1945 Crude OR Adjusted OR

N (%)N (%)OR(95% CI)P-valueOR(95% CI)P-value
Education level
Illiterate2402 (63.29)1393 (36.71)5.50(3.62–8.34)<0.0015.79(3.77–8.88)<0.001
≤diploma3554 (87.09)527 (12.91)1.41(0.92–2.14)0.1141.54(1.003–2.35)0.048
University237 (90.46)25 (9.54)Ref.Ref.Ref.Ref.
Wealth score
Quintile 11362 (71.27)549 (28.73)1.94(1.65–2.27)<0.0011.12(0.94–1.34)0.189
Quintile 21009 (74.19)351 (25.81)1.67(1.40–1.99)<0.0011.13(0.93–1.36)0.217
Quintile 31284 (73.71)458 (26.29)1.72(1.45–2.02)<0.0011.25(1.04–1.49)0.014
Quintile 41162 (79.43)301 (20.57)1.25(1.04–1.49)0.0161.06(0.87–1.28)0.527
Quintile 51367 (82.79)286 (17.21)Ref.Ref.Ref.Ref.
Physical activity
Low1907 (70.24)808 (29.76)1.76(1.55–2.00)<0.0011.76(1.54–2.01)<0.001
Medium2099 (77.43)612 (22.57)1.21(1.06–1.38)0.0041.17(1.02–1.34)0.021
High2187 (80.64)525 (19.36)Ref.Ref.Ref.Ref.
Abdominal obesity
No1305 (82.70)273 (17.30)Ref.Ref.Ref.Ref.
Yes4888 (74.51)1672 (25.49)1.63(1.42–1.88)<0.0011.36(1.17–1.59)<0.001
Crude and adjusted effect of independent variables on 10-year risk for CVD

Discussion

The main objective of present study was to estimate the 10-year CVD risk in the Pars cohort population. The results showed that 23.89% of the study population were in the moderate, high, and very high-risk groups for CVD. Most of the studies that used WHO risk charts, revealed that many people were in the low-risk group. In studies conducted in Iran and Bangladesh, the risk of CVD ≥10% was reported to be 9.8%, and 14.8%, respectively (21, 22). We used revised models to estimate risk in 21 global regions. The observed differences might be attributed to different WHO risk prediction models or different study populations. Given the fact that most participants in the present study aged less than 55 years and since other studies have shown an increase in the CVD risk by age (21), many participants were in the low-risk group. In this study, the prevalence of hypertension, diabetes, and hypercholesterolemia was 12.79%, 8.38%, and 12.80%, respectively. In Iran, the prevalence of hypertension and diabetes was 15.7% and 9.6%, respectively (21, 23). In the present study, smoking prevalence was 14.41%. Smoking was about 47 times higher in males than in females (30.22% vs. 0.64%). In Iran, the prevalence of smoking was 22.9% in males and 0.6% in females (24), and the minimum onset age for smoking was six and seven years old (25, 26). Also, smoking was more prevalent in boys than girls (27). The results of the adjusted model showed that the 10-year risk of CVD was significantly higher in participants with abdominal obesity, those who are illiterate or in individuals with diplomas or lower degrees, and those who have low or moderate physical activity. Also, the 10-year risk of CVD was higher among the participants who were in the third quartile of the wealth score group. We observed that the 10-year risk of CVD was significantly higher in participants who had abdominal obesity. In Iran, about two-thirds of females have abdominal obesity (28). Since abdominal obesity is associated with an increased risk of death (29), it is essential to evaluate the factors determining general and abdominal obesity. Also, the 10-year risk of CVD was significantly higher in participants who were in the third quartile of the wealth score group. Another study showed that the prevalence of diabetes, hyper-cholesterolemia, obesity, and fat intake was significantly higher in the richest group compared to the poorest group (30). Participants with low or moderate physical activity had a higher 10-year CVD risk than others. The 10-year risk of CVD was ≥10% in 29.76% of the people with low physical activities and 19.36% of those with high physical activities. Given the importance of physical activity in the prevention of diseases, such as diabetes, cancer, and CVD, and because increasing the physical activity level is a very simple, practical, and low-cost global strategy leading to a reduction in CVD and mortality in middle ages (31), it is necessary to implement health programs and appropriate interventions to control and prevent chronic diseases by determining the factors related to the duration and type of physical activity. The current study showed that the 10-year risk of CVD was significantly higher in illiterate people. Illiterate people about six times more likely to have CVD risk within the next 10-years than those with academic degrees. Also, in individuals with diplomas or lower degrees, the risk of CVD was higher compared with those with academic degrees. The results of another study consistently confirmed an inverse relationship between education level and CVD and its risk factors. Accordingly, low education level was associated with hypertension, diabetes, and a higher incidence of CVD-related deaths (32). Therefore, it is necessary to increase people’s awareness and knowledge about the risk factors and prevention methods of CVD. The WHO charts can help classify people into different levels of risk. Population-based lifestyle modification strategies can be applied to low-risk populations, while individual consultations and repeated follow-up assessments are needed for moderate-risk populations. Besides, more rigorous treatment strategies are needed for high-risk and very high-risk populations (33). Iran is a developing country experiencing a rapid phase of urbanization and industrialization and is undergoing social and economic transformations. This rapid transformation is accompanied by changes in nutritional and physical activity habits, increasing the prevalence of non-communicable diseases like hypertension and diabetes (34, 35). Since the roles of physical activity, hypertension, and diabetes in the development of CVD are well known, it is important to emphasize the adjustment of modifiable variables and educational policies for a healthier lifestyle. The main strength of the present study was the large sample size and utilization of data from a population-based study. Therefore, the results could be generalized to other populations. Also, as we know this study is the first study with a large sample size in Iran that applied new WHO risk prediction models to estimate the 10-year risk of CVD. However, the main limitation of the present study was its cross-sectional nature. Therefore, a cohort study is needed to confirm the findings. Besides, since the participants were ≥40 years old, the results could not be generalized to people under 40 years.

Conclusion

About one-fourth of the participants had moderate risk and higher of developing CVDs within the next 10-years. The prevalence of CVD risk factors was relatively high. Additionally, education level, physical activity, wealth score, and abdominal obesity may be related to the 10-year risk of CVD. Therefore, it is necessary to increase people’s awareness and knowledge about CVD and its risk factors. It is also essential to implement a lifestyle modification strategy in the study population. In order to reduce the burden of CVD and its consequences, individuals with a ≥10% CVD risk should be identified and be provided with individual counselling and treatment services. Also, future longitudinal cohort studies with an adequate follow-up period are recommended to confirm the findings.

Journalism Ethics considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  29 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

3.  Dietary and non-dietary determinants of central adiposity among Tehrani women.

Authors:  Leila Azadbakht; Ahmad Esmaillzadeh
Journal:  Public Health Nutr       Date:  2007-09-03       Impact factor: 4.022

4.  Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran.

Authors:  Alireza Esteghamati; Mehrshad Abbasi; Siamak Alikhani; Mohamad M Gouya; Alireza Delavari; Mehdi H Shishehbor; Mehrdad Forouzanfar; Alieh Hodjatzadeh; Rashid D Ramezani
Journal:  Am J Hypertens       Date:  2008-05-01       Impact factor: 2.689

5.  Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran.

Authors:  Alireza Esteghamati; Mohamad M Gouya; Mehrshad Abbasi; Alireza Delavari; Siamak Alikhani; Farishid Alaedini; Afshin Safaie; Mehrdad Forouzanfar; Edward W Gregg
Journal:  Diabetes Care       Date:  2007-10-05       Impact factor: 19.112

6.  Differential associations of cardiovascular disease risk factors with relative wealth in urban-dwelling South Africans.

Authors:  N Peer; C Lombard; K Steyn; N Levitt
Journal:  J Public Health (Oxf)       Date:  2015-10-31       Impact factor: 2.341

7.  Epidemiology of Adult Diabetes Mellitus and its Correlates in Pars Cohort Study in Southern Iran.

Authors:  Armin Akbarzadeh; Alireza Salehi; Hossein Molavi Vardanjani; Hossein Poustchi; Abdullah Gandomkar; Mohammad Reza Fattahi; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2019-11-01       Impact factor: 1.354

8.  Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC).

Authors:  Ulf Ekelund; Heather A Ward; Teresa Norat; Jian'an Luan; Anne M May; Elisabete Weiderpass; Stephen J Sharp; Kim Overvad; Jane Nautrup Østergaard; Anne Tjønneland; Nina Føns Johnsen; Sylvie Mesrine; Agnès Fournier; Guy Fagherazzi; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Kuanrong Li; Rudolf Kaaks; Pietro Ferrari; Idlir Licaj; Mazda Jenab; Manuela Bergmann; Heiner Boeing; Domenico Palli; Sabina Sieri; Salvatore Panico; Rosario Tumino; Paolo Vineis; Petra H Peeters; Evelyn Monnikhof; H Bas Bueno-de-Mesquita; J Ramón Quirós; Antonio Agudo; María-José Sánchez; José María Huerta; Eva Ardanaz; Larraitz Arriola; Bo Hedblad; Elisabet Wirfält; Malin Sund; Mattias Johansson; Timothy J Key; Ruth C Travis; Kay-Tee Khaw; Søren Brage; Nicholas J Wareham; Elio Riboli
Journal:  Am J Clin Nutr       Date:  2015-01-14       Impact factor: 7.045

9.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

Authors:  Gregory A Roth; Catherine Johnson; Amanuel Abajobir; Foad Abd-Allah; Semaw Ferede Abera; Gebre Abyu; Muktar Ahmed; Baran Aksut; Tahiya Alam; Khurshid Alam; François Alla; Nelson Alvis-Guzman; Stephen Amrock; Hossein Ansari; Johan Ärnlöv; Hamid Asayesh; Tesfay Mehari Atey; Leticia Avila-Burgos; Ashish Awasthi; Amitava Banerjee; Aleksandra Barac; Till Bärnighausen; Lars Barregard; Neeraj Bedi; Ezra Belay Ketema; Derrick Bennett; Gebremedhin Berhe; Zulfiqar Bhutta; Shimelash Bitew; Jonathan Carapetis; Juan Jesus Carrero; Deborah Carvalho Malta; Carlos Andres Castañeda-Orjuela; Jacqueline Castillo-Rivas; Ferrán Catalá-López; Jee-Young Choi; Hanne Christensen; Massimo Cirillo; Leslie Cooper; Michael Criqui; David Cundiff; Albertino Damasceno; Lalit Dandona; Rakhi Dandona; Kairat Davletov; Samath Dharmaratne; Prabhakaran Dorairaj; Manisha Dubey; Rebecca Ehrenkranz; Maysaa El Sayed Zaki; Emerito Jose A Faraon; Alireza Esteghamati; Talha Farid; Maryam Farvid; Valery Feigin; Eric L Ding; Gerry Fowkes; Tsegaye Gebrehiwot; Richard Gillum; Audra Gold; Philimon Gona; Rajeev Gupta; Tesfa Dejenie Habtewold; Nima Hafezi-Nejad; Tesfaye Hailu; Gessessew Bugssa Hailu; Graeme Hankey; Hamid Yimam Hassen; Kalkidan Hassen Abate; Rasmus Havmoeller; Simon I Hay; Masako Horino; Peter J Hotez; Kathryn Jacobsen; Spencer James; Mehdi Javanbakht; Panniyammakal Jeemon; Denny John; Jost Jonas; Yogeshwar Kalkonde; Chante Karimkhani; Amir Kasaeian; Yousef Khader; Abdur Khan; Young-Ho Khang; Sahil Khera; Abdullah T Khoja; Jagdish Khubchandani; Daniel Kim; Dhaval Kolte; Soewarta Kosen; Kristopher J Krohn; G Anil Kumar; Gene F Kwan; Dharmesh Kumar Lal; Anders Larsson; Shai Linn; Alan Lopez; Paulo A Lotufo; Hassan Magdy Abd El Razek; Reza Malekzadeh; Mohsen Mazidi; Toni Meier; Kidanu Gebremariam Meles; George Mensah; Atte Meretoja; Haftay Mezgebe; Ted Miller; Erkin Mirrakhimov; Shafiu Mohammed; Andrew E Moran; Kamarul Imran Musa; Jagat Narula; Bruce Neal; Frida Ngalesoni; Grant Nguyen; Carla Makhlouf Obermeyer; Mayowa Owolabi; George Patton; João Pedro; Dima Qato; Mostafa Qorbani; Kazem Rahimi; Rajesh Kumar Rai; Salman Rawaf; Antônio Ribeiro; Saeid Safiri; Joshua A Salomon; Itamar Santos; Milena Santric Milicevic; Benn Sartorius; Aletta Schutte; Sadaf Sepanlou; Masood Ali Shaikh; Min-Jeong Shin; Mehdi Shishehbor; Hirbo Shore; Diego Augusto Santos Silva; Eugene Sobngwi; Saverio Stranges; Soumya Swaminathan; Rafael Tabarés-Seisdedos; Niguse Tadele Atnafu; Fisaha Tesfay; J S Thakur; Amanda Thrift; Roman Topor-Madry; Thomas Truelsen; Stefanos Tyrovolas; Kingsley Nnanna Ukwaja; Olalekan Uthman; Tommi Vasankari; Vasiliy Vlassov; Stein Emil Vollset; Tolassa Wakayo; David Watkins; Robert Weintraub; Andrea Werdecker; Ronny Westerman; Charles Shey Wiysonge; Charles Wolfe; Abdulhalik Workicho; Gelin Xu; Yuichiro Yano; Paul Yip; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Theo Vos; Mohsen Naghavi; Christopher Murray
Journal:  J Am Coll Cardiol       Date:  2017-05-17       Impact factor: 24.094

10.  Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome.

Authors:  Leila Jahangiry; Mahdieh Abbasalizad Farhangi; Fatemeh Rezaei
Journal:  J Health Popul Nutr       Date:  2017-11-13       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.